Avitar, Inc.

U.S. patent secured for oral fluid DNA test

Published in Medicine and Law Weekly, October 14th, 2005

Building on its oral fluid technology platform, including its screens for drugs of abuse, Avitar, Inc., announced that it has received a patent for its oral fluid collection device to be used for DNA polymerase chain reaction (PCR)-based testing.

The DNA collection device, (Sample Collection and Delivery Device, U.S. Patent #6,926,678) lends itself to be used in laboratories, hospitals, clinics, community based and public health organizations, law enforcement agencies, and diagnostic product OEMs.

Today, blood testing is the method universally used for DNA testing and disease diagnostics. However, research has shown that oral fluids contain biomarker...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly

Source: Medicine and Law Weekly (2005-10-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry